INTERLEUKIN GENETICS AND ALTICOR: AN UNLIKELY PARTNERSHIP11This case study was written by David Finegold based on interviews conducted on October 1, 2003 at Interleukin in Waltham, Massachusetts. Unless otherwise specified, all quotations that appear in the case were obtained during these interviews. Interviews were conducted by Finegold, Jocelyn Mackie, and Cécile M. Bensimon. This case study is one in a series produced under grants funded by The Seaver Institute and Genome Canada to study models for ensuring ethical decision making in bioscience firms. We would especially like to thank Rahul Dhanda without whose help this case study would not have been possible.